Does Acumen Pharmaceuticals Inc (ABOS) Have What it Takes to be in Your Portfolio Friday?

A rating of 83 puts Acumen Pharmaceuticals Inc (ABOS) near the top of the Biotechnology industry according to InvestorsObserver. Acumen Pharmaceuticals Inc's score of 83 means it scores higher than 83% of stocks in the industry. Acumen Pharmaceuticals Inc also received an overall rating of 73, putting it above 73% of all stocks. Biotechnology is ranked 13 out of the 148 industries.

ABOS has an Overall Score of 73. Find out what this means to you and get the rest of the rankings on ABOS!

See Full ABOS Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 73 means the stock is more attractive than 73 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Acumen Pharmaceuticals Inc Stock Today?

Acumen Pharmaceuticals Inc (ABOS) stock is trading at $5.30 as of 10:01 AM on Friday, Jun 2, a rise of $0.30, or 5.96% from the previous closing price of $5.00. The stock has traded between $4.91 and $5.30 so far today. Volume today is low. So far 21,464 shares have traded compared to average volume of 250,308 shares. Click Here to get the full Stock Report for Acumen Pharmaceuticals Inc stock.